Announcements Trials
Browse Landscape

Status

Completed 3Not yet recruiting 2Terminated 1

Sponsor Class

OTHER 4INDUSTRY 2

Study Type

Interventional 553Observational 6

Sponsor

Cancer Type

Genitourinary 19Breast 6Head & Neck 5Thoracic 4Gastrointestinal 3Tumor-Agnostic 1Other 1Gynecologic 1

Conditions

Breast Neoplasms 6Neurotoxicity Syndromes 1Fatigue 1Colonic Neoplasms 1

Interventions

Surveys and Questionnaires 79Blood Specimen Collection 67palbociclib 40Trastuzumab 34Drug Therapy 30Letrozole 29Anastrozole 27Radiotherapy 26Immunohistochemistry 26Mastectomy, Segmental 22Amplified Fragment Length Polymorphism Analysis 22Fulvestrant 21Biopsy 21exemestane 20Tamoxifen 20Interviews as Topic 20Gene Expression Profiling 20Magnetic Resonance Spectroscopy 19ribociclib 18Specimen Handling 18Mastectomy 18Neoadjuvant Therapy 17Paclitaxel 16High-Energy Shock Waves 16Capecitabine 16trastuzumab deruxtecan 15Mammography 15Psychiatric Rehabilitation 14Polymerase Chain Reaction 13Observation 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Observational × Docetaxel × Breast × Clear all
NCT06684054 2024-11-12

STFREiYTNBC

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

Not yet recruiting
30 enrolled
Breast

Breast Neoplasms

NCT03393741 2024-06-25

Pharmacodynamic Biomarkers of Standard Anti-microtubule Drugs as Assessed by Early Tumor Biopsy

University of Wisconsin, Madison

Terminated
5 enrolled
Breast

Breast Neoplasms

NCT05131893 2021-11-23

Neoadjuvant Treatment of Breast Cancer

National Institute of Oncology, Hungary

Not yet recruiting
300 enrolled
Breast

Breast Neoplasms

NCT00755313 2017-11-24

Effects of Chemotherapy on the Brain in Women With Newly Diagnosed Early-Stage Breast Cancer

University of California, San Francisco

Completed
81 enrolled
Breast

Breast Neoplasms, Fatigue, Neurotoxicity Syndromes

NCT02479217 2017-02-17

Safety of Xeloda in Solid Tumours

Hoffmann-La Roche

Completed
1,268 enrolled
BreastGastrointestinal

Breast Neoplasms, Colonic Neoplasms

NCT01777945 2016-08-19

XEBRA Study: An Observational Study of Xeloda (Capecitabine) in Combination With Docetaxel in First Line in Participants With HER2-Negative Metastatic Breast Cancer

Hoffmann-La Roche

Completed
46 enrolled 13 charts
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡